Antimuscarinics and overactive bladder: other mechanism of action

• 資料種別: 記事
• タイトル: Antimuscarinics and overactive bladder: other mechanism of action
• 著者標目: Osamu Yamaguchi
• 出版年月日等: 2009-08-19
• 出版年（W3CDTF）: 2009-08-19
• タイトル（掲載誌）: Neurourology and Urodynamics
• 巻号年月日等（掲載誌）: 29 1
• 掲載巻: 29
• 掲載号: 1
• 掲載ページ: 112-115
• 掲載年月日（W3CDTF）: 2009-08-19
• ISSN（掲載誌）: 07332467
• 出版事項（掲載誌）: Wiley
• 件名標目: Afferent Pathways; Urinary Bladder, Overactive; Urinary Bladder; Sensation; Muscarinic Antagonists; Fibroblasts; Mechanotransduction, Cellular; Receptors, Muscarinic; Acetylcholine; Treatment Outcome; Animals; Humans; Urothelium; Muscle Contraction
• 対象利用者: 一般
• 標準番号（その他）: PMID : 19693952
• DOI: 10.1002/nau.20796; https://doi.org/10.1002/nau.20796
• 作成日（W3CDTF）: 2009-08-19
• オンライン閲覧公開範囲: インターネット公開
• 著作権情報: http://onlinelibrary.wiley.com/termsAndConditions#vor
• 関連情報（URI）: https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fnau.20796; https://onlinelibrary.wiley.com/doi/pdf/10.1002/nau.20796
• 参照: Pulse Diode Laser Irradiation (830 nm) of Lumbosacral Spinal Roots Diminished Hyperreflexia‐Induced by Acetic Acid or Prostaglandin E₂ Infusion in Rat Urinary Bladder; https://cir.nii.ac.jp/crid/1360004235754518144; β-Adrenoceptor agonist effects in experimental models of bladder dysfunction; https://cir.nii.ac.jp/crid/1360567182380737664; Clinical Efficacy and Safety of Imidafenacin as Add-on Treatment for Persistent Overactive Bladder Symptoms Despite α-Blocker Treatment in Patients With BPH: The ADDITION STUDY; https://cir.nii.ac.jp/crid/1360567182498761344; Long‐term safety and efficacy of antimuscarinic add‐on therapy in patients with overactive bladder who had a suboptimal response to mirabegron monotherapy: A multicenter, randomized study in Japan (MILAI II study); https://cir.nii.ac.jp/crid/1360848660462754688
• 連携機関・データベース: 国立情報学研究所 : CiNii Research; https://cir.nii.ac.jp/
• 提供元機関・データベース: Crossref; https://www.crossref.org

• 要約等: <jats:title>Abstract</jats:title><jats:p>Antimuscarinics are considered first‐line treatment for patients with overactive bladder (OAB). However, the ...